Biotechnology Fund

Investor type

VC

Founded

2014

AUM

-

Location

Tehran, Tehran Province, Iran

Investment Ticket

$1-5 m

Investment Stage

Seed Series A Series B Late Stage (Series C+)

Region of investment

Middle East Asia
Investor profile last updated: 21 August, 2026

Profile

The Biotechnology Fund is a venture capital firm based in Iran, specializing in biotechnology investments. This organization focuses on fostering innovative biotech developments and supporting the bio-innovation ecosystem in the region. Their team consists of experts across various biotech sub-fields with a robust background in venture capital investments. The firm makes extensive efforts to support new biotechnology ventures that have the potential to revolutionize the industry locally and internationally.

Biotechnology Fund primarily invests in early-stage biotechnology companies, providing venture capital support and financial advisory to innovative projects. Their investment strategy encompasses seed to late-stage investments, targeting companies within Iran. They provide resources for financial consulting, project evaluation, and fundraising, essential for emerging biotech firms. The firm collaborates with various strategic partners in science and technology sectors to ensure effective growth and support for their portfolio companies.

The firm has supported multiple biotech projects and has actively participated in numerous technology exhibitions and conventions. While specific notable investments are not listed, the firm is broadly engaged in collaborations that advance the biotechnology sector in Iran, particularly focusing on innovative and scalable technologies. They aspire to create a vibrant biotech ecosystem through their strategic investments and partnerships.

Industry

HealthTech Biotechnology Business Services (B2B) Life Sciences

Contacts

Name
Title
Email
avatar
mohammad javad Investment Manager
Investment Manager
-
Upgrade to see contacts
avatar
zGZHCOuXJPgQi24N zGZHCOuXJPgQi24N
zGZHCOuXJPgQi24N
avatar
zGZHCOuXJPgQi24N zGZHCOuXJPgQi24N
zGZHCOuXJPgQi24N
avatar
zGZHCOuXJPgQi24N zGZHCOuXJPgQi24N
zGZHCOuXJPgQi24N
avatar
zGZHCOuXJPgQi24N zGZHCOuXJPgQi24N
zGZHCOuXJPgQi24N
Investment-team contacts for Biotechnology Fund — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Biotechnology Fund

Biotechnology Fund is a venture capital firm. It backs companies at Seed, Series A, Series B and Late Stage (Series C+), writing tickets of $1-5 m.
Biotechnology Fund is located in Tehran, Tehran Province, Iran.
Biotechnology Fund was founded in 2014.
Biotechnology Fund invests in companies and startups in HealthTech, Biotechnology, Business Services (B2B), Life Sciences.
Biotechnology Fund invests in companies and startups in Middle East, Asia.
Biotechnology Fund invests in companies and startups at Seed, Series A, Series B, Late Stage (Series C+).
Biotechnology Fund usually invests $1-5 m on average.
Biotechnology Fund can be reached through its website biotechfund.ir and its LinkedIn page. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Biotechnology Fund — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Biotechnology Fund directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 21 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.